TGFB1 and cancer: ECM components such as the binding between tenascins and TGF-β isoforms [250] and EGF-domain of fibronectin fibrils [251] stimulate TGF-β signaling pathway and EMT process in normal cells, may potentially influence EMT in cancer cells (Fig. 3A).